Shoumin Zhu and colleagues conducted a series of in vitro assays and 3D gastric organoid cultures using mouse models and human tissues to determine the effect of DARPP-32 on the activation of IGF1R and STAT3 signaling, which is crucial for the onset of gastric cancer. This evidence concerns the gene IGF1R and gastric cancer.